VU LSC-EMBL Partnership for Genome Editing Technologies

EMBL and VU LSC, recognising the scientific and technological potential of uniting their complementary strengths in the field of targeted genome modification, decided to intensify existing links and build further institutional synergies by creating the Partnership for Genome Editing Technologies.

partnerships Archives, Page 7 of 9

VU LSC-EMBL Partnership for Genome Editing Technologies

The Head of EMBL Visited Vilnius University to Discuss the Development of New Genome Editing Technologies and their Applications

MIMS Symposium 2022: a platform for showcasing collaboration in basic, translational and clinical research

partnerships Archives

Celebrating Lithuania-EMBL cooperation on life science research

CRISPR-Cas Tools and Technologies

Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors - ScienceDirect

RCSB PDB - 7LYS: Cryo-EM structure of CasPhi-2 (Cas12j) bound to crRNA and DNA

VU Gyvybės mokslų centras - Three laboratories at the Life Sciences Centre of Vilnius University, a Partnership Institute of the European Molecular Biology Laboratory for genome editing (VU LSC-EMBL Partnership Institute), Lithuania

Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling, Cellular & Molecular Biology Letters

Research Plans in EMBL's Programme for 2022–2026, 'Molecules to Ecosystems' by European Molecular Biology Laboratory (EMBL) - Issuu

MIMS Symposium 2022: a platform for showcasing collaboration in basic, translational and clinical research